Aucatzyl

News

NICE backs NHS use of Autolus' leukaemia CAR-T

Hundreds of people with an aggressive leukaemia will be able to access a CAR-T therapy developed by UK biotech Autolus after a NICE recommendation.

News

Autolus closes on EU okay for leukaemia cell therapy

The CHMP backed approval of Autolus' leukaemia CAR-T Aucatzyl, as well as drugs from GSK, Roche, SpringWorks, and others, at its May meeting.

News

window into laboratory with scientist hard at work

Autolus bags FDA approval for leukaemia cell therapy

Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with aggressive blood cancer acute lymphoblastic leukaemia (ALL).

NICE backs NHS use of Autolus' leukaemia CAR-T

Autolus closes on EU okay for leukaemia cell therapy

Autolus bags FDA approval for leukaemia cell therapy

New biotech Avere plots listing via NextCure merger

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks